MedTrace Logo

Probiotic BIO-25 as a Supplement to Statins for the Treatment of Hypercholesterolemia

NCT01849185 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-05-08

No results posted yet for this study

Summary

The primary objective is to examine whether probiotics given to hypercholesterolemic patients treated with statins, would further decrease LDL-Cholesterol levels.

The secondary objective is to examine whether adding of probiotics to statins would decrease fasting glucose levels and glycolysated hemoglobin

Conditions

Interventions

OTHER

Food supplement

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Principal Investigators

  • Tatiana Berlin, MD · Division of Cardiology Meir MC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2014-01-31
Completion
2014-03-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01849185 on ClinicalTrials.gov